A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Teva Pharmaceutical ( (TEVA)) has provided an update. Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange ...

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

Revenue growth is due to growth in Teva's US generics business, the company's main market, among other things due to sales of ...

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the ...

Two pharmaceutical companies have been found liable in Baltimore's opioid epidemic. McKesson and AmerisourceBergen have been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investing.com – Israel stocks were lower after the close on Sunday, as losses in the Real Estate, Financials and Insurance sectors led shares lower. At the close in ...